medRxiv
medRxiv is a health sciences preprint website where researchers share medical, clinical, epidemiology, and public health manuscripts before journal peer review.
What medRxiv is
medRxiv is a website at medrxiv.org for sharing health sciences manuscripts before journal peer review. It is pronounced "med archive" and serves research communities in clinical medicine, epidemiology, public health, and related fields that need fast access to emerging findings.
Health preprints
A medRxiv preprint is an early research manuscript, not a certified medical recommendation. The speed is useful: researchers can see methods, results, and ideas before a journal article is finished. The tradeoff is also important. Medical and public health claims can affect patient decisions, news coverage, and policy debates, so readers need to check whether later peer review, replication, correction, or publication changes the story.
Scope and subject areas
medRxiv covers health sciences rather than general biology. Its subject areas include clinical research, epidemiology, infectious disease, health policy, public health, medical education, and other fields where early findings may matter to researchers, clinicians, and institutions. The platform is a companion to bioRxiv, but the health context makes the reading rules stricter.
Submission and screening
Authors can submit manuscripts before or while submitting them to a journal, but medRxiv says manuscripts should not already have been accepted, published, or posted elsewhere. Submissions are screened before posting, yet screening is not the same thing as journal peer review. It is a front-door check, not a final scientific verdict.
Versions and journal links
Version history is central to reading medRxiv well. A posted manuscript may be updated after feedback, linked to a journal article, or left as a preprint. The medRxiv FAQ notes that versions remain on the site and that links to published versions are usually added when publication information becomes available.
Metrics and indexing
medRxiv pages can show article views, PDF downloads, and attention signals, and the platform is indexed by major scholarly discovery services. These signals make early work findable, but they should be read as visibility markers. A downloaded or widely discussed preprint still needs careful evaluation of study design, sample size, statistics, conflicts, and later evidence.
openRxiv context
openRxiv is the organizational home for bioRxiv and medRxiv. Its history places medRxiv in a wider movement toward preprints: sharing manuscripts earlier, preserving versions, speeding feedback, and making research more open while still preserving the distinction between early circulation and peer-reviewed publication.
Why it matters
medRxiv matters because health research often moves under public pressure. During outbreaks, policy debates, and urgent clinical questions, early evidence can help scientists coordinate and avoid duplicated work. The same openness can also amplify preliminary findings before experts have tested them. The website is most useful when readers keep both truths in view: faster sharing is powerful, and medical uncertainty needs visible labels.
WHOIS domain data
Data pulled: June 1, 2026View current WHOIS record
- Domain
- medrxiv.org
- IP address
- 104.21.11.180
- Registrar
- CSC Corporate Domains, Inc.
- WHOIS server
- http://whois.cscglobal.com
- Referral URL
- http://www.cscglobal.com/global/web/csc/digital-brand
- Created
- November 21, 2017
- Updated
- November 22, 2025
- Expires
- November 21, 2026
- Nameservers
- jen.ns.cloudflare.com (172.64.34.185); vin.ns.cloudflare.com (108.162.193.245)
- Domain status
- clientTransferProhibited
- DNSSEC
- unsigned